Episode 35: ASCO GU 2026 Commentary: Prostate Cancer

from The View on GU | with Lalani and Wallis · host Dr. Aly-Khan Lalani & Dr. Christopher Wallis

Dr. Aly-Khan Lalani and Dr. Christopher Wallis also highlight Canadian-led innovation in the GUNS trial and early data from the PAnTHA study, and discuss how Prostate Cancer Working Group 4 may redefine trial design. Episode 35 is the first of three ASCO GU recap episodes, so don’t miss Episode 36 on bladder cancer and Episode 37 on kidney cancer!The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Pfizer, Tolmar, AbbVie, Astellas, Eisai, Ipsen, Merck, Bayer, TerSera.

Episode metadata supplied by the publisher feed · Published Mar 6, 2026

Embed this episode

Attribution link and audio player

Ready to play

Episode 35: ASCO GU 2026 Commentary: Prostate Cancer

0:00 33:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The View on GU | with Lalani and Wallis?

This episode is 33 minutes long.

When was this The View on GU | with Lalani and Wallis episode published?

This episode was published on March 6, 2026.

Can I download this The View on GU | with Lalani and Wallis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!